Equities research analysts at StockNews.com started coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the stock.
Oragenics Trading Up 0.8 %
Shares of NYSE OGEN opened at $0.31 on Friday. Oragenics has a 12-month low of $0.25 and a 12-month high of $4.00. The company has a market cap of $3.77 million, a price-to-earnings ratio of -0.04 and a beta of 0.40. The stock’s 50 day simple moving average is $0.34 and its 200 day simple moving average is $0.55.
About Oragenics
Featured Stories
- Five stocks we like better than Oragenics
- What Are Dividend Challengers?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Investing In Automotive Stocks
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.